Publications

5674 Results

What Keeps Patients Out of Clinical Trials? [Editorial]

Authors
L Minasian;J Unger
Journal / Conference
JCO Oncology Practice Mar;16(3):125-127
Year
2020
Research Committee(s)
Cancer Care Delivery
PMID
PMID32074016

A Phase III, Randomized Study of Nivolumab (Opdivo) Plus AVD or Brentuximab Vedotin (Adcetris) Plus AVD in Patients (Age >/= 12 years) with Newly Diagnosed Advanced Stage Classical Hodgkin Lymphoma (SWOG Intergroup S1826)

Authors
A Herrera;B Kahl
Journal / Conference
Hematologist [Clinical Trials Corner] Sept 1 Vol 17, Issue 5
Year
2020
Research Committee(s)
Lymphoma
Study Number(s)
S1826

Results of the NRG Oncology/RTOG 0848 Adjuvant Chemotherapy Question-Erlotinib+Gemcitabine for Resected Cancer of the Pancreatic Head: A Phase II Randomized Clinical Trial

Authors
R Abrams;K Winter;H Safran;K Goodman;W Regine;A Berger;M Gilllin;PA Philip;A Lowy;A Wu;T DePetrillo;B Corn;S Seaward;M Haddock;S Song;Y Jiang;B Fisher;A Katz;S Mehta;C Willett;C Crane
Journal / Conference
American Journal of Clinical Oncology Mar;43(3):173-179
Year
2020
Research Committee(s)
Gastrointestinal
PMID
PMID31985516
PMC
PMC7280743
Study Number(s)
CTSU/R0848

Risk factors for bisphosphonate-associated osteonecrosis of the jaw in the prospective randomized trial of adjuvant bisphosphonates for early-stage breast cancer (SWOG 0307)

Authors
D Kizub;J Miao;M Schubert;A Paterson;M Clemons;E Dees;J Ingle;C Falkson;W Barlow;G Hortobagyi;J Gralow
Journal / Conference
Supportive Care in Cancer Sep 15. doi: 10.1007/s00520-020-05748-8. Online ahead of print
Year
2020
Research Committee(s)
Breast
PMID
PMID32929540
Study Number(s)
S0307

Randomized Trial of Lenalidomide Versus Observation in Smoldering Multiple Myeloma

Authors
S Lonial;S Jacobus;R Fonseca;M Weiss;S Kumar;R Orlowski;J Kaufman;A Yacoub;F Baudi;T O'Brien;J Matous;D Anderson;D Emmons;A Mahrindra;L Wagner;M Dhodapkar;SV Rajkumar
Journal / Conference
Journal of Clinical Oncology Apr 10;38(11):1126-1137
Year
2020
Research Committee(s)
Myeloma
PMID
PMID31652094
PMC
PMC7145586
Study Number(s)
CTSU/E3A06

Developments in continuous therapy and maintenance treatment approaches for patients with newly diagnosed multiple myeloma

Authors
M Dimopoulos;A Jakubowiak;P McCarthy;R Orlowski;M Attal;J Blade;H Goldschmidt;K Weisl;K Ramasamy;S Zweegman;A Spencer;J Huang;J Lu;K Sunami;S Lida;W-J Chng;S Holstein;A Rocci;T Skacel;R Labotka;A Palumbo;K Anderson
Journal / Conference
Blood Cancer Journal Feb 13;10(2):17
Year
2020
Research Committee(s)
Myeloma
PMID
PMID32054831
PMC
PMC7018731
Study Number(s)
S0777

Phase III Study of Adjuvant Ipilimumab (3 or 10 mg/kg) Versus High-Dose Interferon Alfa-2b for Resected High-Risk Melanoma: North American Intergroup E1609

Authors
A Tarhini;S Lee;FS Hodi;U Rao;G Cohen;O Hamid;L Hutchins;J Sosman;H Kluger;Z Eroglu;H Kooon;D Lawrence;K Kendra;D Minor;C Lee;M Albertini;L Flaherty;T Petrella;H Streicher;V Sondak;J Kirkwood
Journal / Conference
Journal of Clinical Oncology Feb 20;38(6):567-575
Year
2020
Research Committee(s)
Melanoma
PMID
PMID31880964
PMC
PMC7030886
Study Number(s)
CTSU/E1609

Serological evidence of infections is associated with extent and intensity of intra-prostatic inflammation in men without prostate cancer or indication for biopsy in the placebo arm of the Prostate Cancer Prevention Trial

Authors
M Langston;M Umbehr;J Barber;C Drake;AM De Marzo;P Goodman;B Gurel;SM Lippman;SM Lucia;W Nelson;H Parnes;C Tangen;IM Thompson;EA Platz;S Sutcliffe
Journal / Conference
American Society for Preventative Oncology annual meeting (March 22-24, 2020, Tucson, AZ), poster
Year
2020
Research Committee(s)
Cancer Control
Study Number(s)
SWOG-9217

A Phase II Study of Isatuximab (Sar650984) (Nsc-795145) for Patients with Previously Treated Al Amyloidosis (SWOG S1702; NCT#03499808)

Authors
T Parker;K Chansky;V Sanchorawala;H Landau;E Campagnaro;P Kapoor;N Neparidze;P Hagen;S Sarosiek;A Hoering;R Orlowski
Journal / Conference
International Symposium on Amyloidosis (virtual September 14-18, 2020, Tarragona, Spain), oral, #OP35
Year
2020
Research Committee(s)
Myeloma
Study Number(s)
S1702

Mendelian randomization analysis of n-6 polyunsaturated fatty acid levels and pancreatic cancer risk

Authors
D Ghoneim;J Zhu;W Zheng;J Long;H Murff;F Ye;P Goodman;D Albanes;C Fuchs;JM Gaziano;I Thompson;L Amundadottir;P Kraft;A Klein;R Stolzenberg-Solomon;X-O Shu;L Wu
Journal / Conference
Cancer Epidemiology Biomarkers & Prevention Dec;29(12):2735-2739
Year
2020
Research Committee(s)
Cancer Control, Prevention, Screening, and Surveillance, Prevention, Screening, and and Surveillance
PMID
PMID32967863
PMC
PMC8195110
Study Number(s)
S0000, SWOG-9217